retatrutide cognitive benefits Unapproved weight loss drug causes extreme side effects Retatrutide—A Game Changer in Obesity
Description
Regulatory Context Research Procurement Status Retatrutide is an investigational new drug not approved by the FDA for human use
Diabetes care portfolio including GLP-1 receptor agonist therapies
Available online: 182.Hampl S.E., Hassink S.G., Skinner A.C., Armstrong S.C., Barlow S.E., Bolling C.F., Avila Edwards K.C., Eneli I., Hamre R., Joseph M.M., et al
Retatrutide achieves greater weight loss in less time
